AN INNOVATIVE REPURPOSING OF MEFLOQUINE; ASSESSMENT OF ITS THERAPEUTIC EFFICACY IN TREATING CRYPTOSPORIDIUM PARVUM INFECTION OF BOTH IMMUNOCOMPETENT AND IMMUNOCOMPROMIZED MICE

Cryptosporidium parvum is a protozoan parasite can affect humans, worldwide, causing asymptomatic infections or diarrheal disease, which may be life-threatening in immunocompromised and neonatal individuals. Mefloquine is one of the most promising anti-parasitic drugs. The present report aimed to st...

Celý popis

Podrobná bibliografie

Hlavní autoři:	BOSHRA HUSSIEN, HEBA KHALIL, RABAB ZALAT, RABAB SELEM, NAGWA ALY
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	The Egyptian Society of Parasitology 2017-08-01
Edice:	Journal of the Egyptian Society of Parasitology
Témata:	Cryptosporidium parvum Mefloquine Nitazoxanide In-Vivo
On-line přístup:	https://jesp.journals.ekb.eg/article_77763_5b62eeaa221ddbf72c46b3b829a2ddf2.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!